5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Pancreatic tissue, and islets in particular, are enriched in expression of the interleukin-1 receptor type I (IL-1R). Because of this enrichment, islet β-cells are exquisitely sensitive to the IL-1R ligands IL-1α and IL-1β, suggesting that signaling through this pathway regulates health and function of islet β-cells.

          Methods

          Herein, we report a targeted deletion of IL-1R in pancreatic tissue (IL-1R Pdx1−/− ) in C57BL/6J mice and in db/db mice on the C57 genetic background. Islet morphology, β-cell transcription factor abundance, and expression of the de-differentiation marker Aldh1a3 were analyzed by immunofluorescent staining. Glucose and insulin tolerance tests were used to examine metabolic status of these genetic manipulations. Glucose-stimulated insulin secretion was evaluated in vivo and in isolated islets ex vivo by perifusion.

          Results

          Pancreatic deletion of IL-1R leads to impaired glucose tolerance, a phenotype that is exacerbated by age. Crossing the IL-1R Pdx1−/− with db/db mice worsened glucose tolerance without altering body weight. There were no detectable alterations in insulin tolerance between IL-1R Pdx1−/− mice and littermate controls. However, glucose-stimulated insulin secretion was reduced in islets isolated from IL-1R Pdx1−/− relative to control islets. Insulin output in vivo after a glucose challenge was also markedly reduced in IL-1R Pdx1−/− mice when compared with littermate controls. Pancreatic islets from IL-1R Pdx1−/− mice displayed elevations in Aldh1a3, a marker of de-differentiation, and reduction in nuclear abundance of the β-cell transcription factor MafA. Nkx6.1 abundance was unaltered.

          Conclusions

          There is an important physiological role for pancreatic IL-1R to promote glucose homeostasis by suppressing expression of Aldh1a3, sustaining MafA abundance, and supporting glucose-stimulated insulin secretion in vivo.

          Highlights

          • Pancreatic deletion of IL-1R impairs glucose tolerance in young and old male mice.

          • Pancreatic deletion of IL-1R worsens glucose tolerance in obese db/db mice.

          • Deletion of IL-1R triggers expression of the de-differentiation marker Aldh1a3.

          • IL-1 signaling in pancreatic tissue influences islet health and function.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          Targeting inflammation in the treatment of type 2 diabetes: time to start.

          The role of inflammation in the pathogenesis of type 2 diabetes and associated complications is now well established. Several conditions that are driven by inflammatory processes are also associated with diabetes, including rheumatoid arthritis, gout, psoriasis and Crohn's disease, and various anti-inflammatory drugs have been approved or are in late stages of development for the treatment of these conditions. This review discusses the rationale for the use of some of these anti-inflammatory treatments in patients with diabetes and what we could expect from their use. Future immunomodulatory treatments may not target a specific disease, but could instead act on a dysfunctional pathway that causes several conditions associated with the metabolic syndrome.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes.

            Diabetes is associated with a deficit of insulin-producing β-cells. Animal studies show that β-cells become dedifferentiated in diabetes, reverting to a progenitor-like stage, and partly converting to other endocrine cell types.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Inactivation of specific β cell transcription factors in type 2 diabetes.

              Type 2 diabetes (T2DM) commonly arises from islet β cell failure and insulin resistance. Here, we examined the sensitivity of key islet-enriched transcription factors to oxidative stress, a condition associated with β cell dysfunction in both type 1 diabetes (T1DM) and T2DM. Hydrogen peroxide treatment of β cell lines induced cytoplasmic translocation of MAFA and NKX6.1. In parallel, the ability of nuclear PDX1 to bind endogenous target gene promoters was also dramatically reduced, whereas the activity of other key β cell transcriptional regulators was unaffected. MAFA levels were reduced, followed by a reduction in NKX6.1 upon development of hyperglycemia in db/db mice, a T2DM model. Transgenic expression of the glutathione peroxidase-1 antioxidant enzyme (GPX1) in db/db islet β cells restored nuclear MAFA, nuclear NKX6.1, and β cell function in vivo. Notably, the selective decrease in MAFA, NKX6.1, and PDX1 expression was found in human T2DM islets. MAFB, a MAFA-related transcription factor expressed in human β cells, was also severely compromised. We propose that MAFA, MAFB, NKX6.1, and PDX1 activity provides a gauge of islet β cell function, with loss of MAFA (and/or MAFB) representing an early indicator of β cell inactivity and the subsequent deficit of more impactful NKX6.1 (and/or PDX1) resulting in overt dysfunction associated with T2DM.
                Bookmark

                Author and article information

                Contributors
                Journal
                Mol Metab
                Mol Metab
                Molecular Metabolism
                Elsevier
                2212-8778
                06 June 2018
                August 2018
                06 June 2018
                : 14
                : 95-107
                Affiliations
                [1 ]Pennington Biomedical Research Center, Baton Rouge, LA, 70808, USA
                [2 ]Department of Surgery, University of Tennessee Health Science Center, Knoxville, TN, 37920, USA
                [3 ]Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, 45267, USA
                [4 ]Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Jupiter FL, 33458, USA
                Author notes
                []Corresponding author. Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA, 70808, USA. Fax: +225 763 0274. Jason.collier@ 123456pbrc.edu
                Article
                S2212-8778(18)30304-1
                10.1016/j.molmet.2018.06.003
                6034063
                29914854
                cf798dc3-75e5-4e5d-9096-38ea7eb72982
                © 2018 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 24 March 2018
                : 30 May 2018
                : 2 June 2018
                Categories
                Original Article

                cytokine,glucose homeostasis,inflammation,insulin,islet
                cytokine, glucose homeostasis, inflammation, insulin, islet

                Comments

                Comment on this article